Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Cantor Fitzgerald Remains Sidelined on Allscripts (MDRX) Following Analyst Meeting
March 22, 2017 7:34 AM EDTCantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More
Allscripts (MDRX) PT Raised to $13 at Cowen Following Investor Conference; 'Incrementally Positive'
March 22, 2017 6:09 AM EDTCowen analyst Charles Rhyee raised its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $12.00) while maintaining a Market Perform rating, suggesting an incrementally positive outlook on the company following the Investor Conference.
Rhyee comments, "Following the Investor Conference, we are incrementally... More
Allscripts (MDRX) volatility flat into investor day
March 20, 2017 8:52 AM EDTAllscripts (NASDAQ: MDRX) April call option implied volatility is at 30, May is at 31; compared to its 52-week range of 25 to 46 into a company hosted investor day on March 21.
... More